Scientific Articles

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma

19 Oct 2022

 

Neil D Gross, David M Miller, Nikhil I Khushalani, Vasu Divi, Emily S Ruiz, Evan J Lipson, Friedegund Meier, Yungpo B Su, Paul L Swiecicki, Jennifer Atlas, Jessica L Geiger, Axel Hauschild, Jennifer H Choe, Brett G M Hughes, Dirk Schadendorf, Vishal A Patel, Jade Homsi, Janis M Taube, Annette M Lim, Renata Ferrarotto, Howard L Kaufman, Frank Seebach, Israel Lowy, Suk-Young Yoo, Melissa Mathias, Keilah Fenech, Hyunsil Han, Matthew G Fury, Danny Rischin

The New England Journal of Medicine, 2022 Sep. 12

Abstract link

 

 

 

 

 

 

 

 

Copyright © 2022 Massachusetts Medical Society.

Forse può anche interessarti

Privacy Overview
AIOM

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.